Most Read Articles
4 days ago
New drug applications approved by US FDA as of 01 - 15 January 2020 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Product Highlight - Bexsero

20 Dec 2019
BEXSERO - The new vaccine for meningococcal B prevention

• The only meningococcal B vaccine indicated for 2 months old onwards
• Meningococcal B accounted for 50% of meningococcal disease in Hong Kong in 2018
• 4 antigenic components for broader meningococcal B prevention
• Flexible dosage schedule
• FDA & EMA approved

References:
1. Bexsero Hong Kong Prescribing Information 2019.
2. CHP. Communicable Diseases Watch. Jan 2-Feb 9 2019 Weeks 5-6. Vol 16 Issue No. 3.


Further information is available in MIMS section 12b.


Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacy - Hong Kong digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
New drug applications approved by US FDA as of 01 - 15 January 2020 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.